
The COVID-19 vaccines rolling out globally were developed to target the original version of the virus detected in late 2019. While they seem to work against newer versions, there's a concern the shots eventually might lose their effectiveness if variants evolve enough.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3y5M0Js
via
IFTTT
0 comments:
Post a Comment